Be on the lookout for a price bounce soon.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESP advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on January 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ESP as a result. In of 118 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ESP turned negative on January 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .
ESP moved below its 50-day moving average on January 02, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ESP broke above its upper Bollinger Band on December 26, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ESP entered a downward trend on December 24, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.654) is normal, around the industry mean (4.050). P/E Ratio (13.585) is within average values for comparable stocks, (40.807). ESP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.638). Dividend Yield (0.023) settles around the average of (0.096) among similar stocks. P/S Ratio (1.710) is also within normal values, averaging (134.192).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ESP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a maker of custom magnetic components and power supplies
Industry ElectricalProducts
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EKJFX | 13.62 | 0.15 | +1.11% |
Allspring Premier Large Co Gr R6 | |||
DTCAX | 18.87 | 0.18 | +0.96% |
BNY Mellon Sust US Equity A | |||
JLCVX | 73.38 | 0.69 | +0.95% |
JHancock Fundamental Large Cap Core R5 | |||
EMEAX | 11.15 | 0.06 | +0.54% |
Ashmore Emerging Markets Equity A | |||
LHCCX | 18.45 | -0.13 | -0.70% |
Lord Abbett Health Care C |
A.I.dvisor tells us that ESP and NXT have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESP and NXT's prices will move in lockstep.
Ticker / NAME | Correlation To ESP | 1D Price Change % | ||
---|---|---|---|---|
ESP | 100% | +0.51% | ||
NXT - ESP | 23% Poorly correlated | -2.39% | ||
GWH - ESP | 21% Poorly correlated | +3.45% | ||
ELVA - ESP | 21% Poorly correlated | +0.40% | ||
HAYW - ESP | 21% Poorly correlated | +1.07% | ||
NEOV - ESP | 20% Poorly correlated | -6.50% | ||
More |